Adopting appropriate eligibility criteria for research and clinical programs in which powered exoskeletal-assisted walking devices are used remains a challenge to avoid risk of injury and to encourage the successful use of these devices. Reducing the risk of fracture is a primary concern when establishing eligibility criteria. Evidence from a three-site clinical trial supports the use of screening criteria for bone mineral density at the knee to permit safe use of exoskeletal devices.
|Title of host publication||Biosystems and Biorobotics|
|Publisher||Springer Science and Business Media Deutschland GmbH|
|Number of pages||5|
|State||Published - 2022|
|Name||Biosystems and Biorobotics|